Many pulmonary diseases, including asthma, COPD, and interstitial pulmonary fibrosis (IPF) are linked to and made worse by obesity with increased exacerbations, patient-reported decreased quality of life, and resistance to therapy (Ray et al
You can learn more about the benefits and risks of compounding pharmacies here
In recent months, Eli Lilly, the maker of Zepbound and Mounjaro, and Novo Nordisk, the maker of Ozempic and Wegovy, have each said that they are able to meet the demand for the medications after facing shortages since 2022 due to the drugs' growing popularity
Not every patient is a candidate those with certain thyroid, gallbladder, or pancreatic conditions may not qualify
Parikh is a board-certified facial plastic surgeon in Palo Alto, CA No
Dopaminergic modulation of spectral and spatial characteristics of Parkinsonian subthalamic nucleus beta bursts